The proposal for a TRIPS waiver, made initially by India and South Africa last October, received additional impetus in May when U.S announced its initial support of the waiver and the text-based negotiations at WTO TRIPS Council.
Read moreThe Award is IFPMA and Speak Up Africa's flagship program celebrating the pioneering young entrepreneurs whose work advances health across the region by helping Award winners bring their innovations to life.
Read moreIFPMA, IPASA, KAPI, AREPI and LIPA are hosting a first conversation with Holistic Drug Discovery and Development (H3D) Foundation on 27 July from 14:00 to 15:30 CET to hear the inspiring H3D story, discover its capacity development programs for local talent in Africa, and learn how IFPMA members can get involved.
Read moreThe virtual session on Young African Public Health Leadership is co-hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Chatham House Global Health Programme.
Read moreThe African Medicines Agency (AMA) creates an unprecedented opportunity for improved regulatory reliance and strengthening resulting in speeder access to medicines and vaccines for people throughout the continent.
Read moreThe IFPMA is joining hands with local Pharmaceutical Industry Associations from across the African continent to tackle the topic of falsified medicines and chart a robust response to eliminate falsified medicines in the region.
Read moreJoin members of the innovative biopharmaceutical industry in marking this year’s World Intellectual Property Day on 26 April 2021 for the launch of the IP Principles for Advancing Cures and Therapies (IP PACT).
Read moreDIA Europe is the must-attend event for all life science professionals working in drug development, from discovery to marketed use. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial discussions across several topics.
Read more